COMMUNIQUÉS West-GlobeNewswire

Breadth of data at ECTRIMS underpins Novartis' relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden

10/10/2018 - 07:16

33 abstracts from the leading MS portfolio include data for Gilenya® (fingolimod), and investigational drugs siponimod (BAF312) and ofatumumab (OMB157) New research will be presented on neurofilaments, a biomarker for [...]

GenesisCare and Telix Enter into Strategic Collaboration Agreement to Accelerate Patient Access to New Treatments

10/10/2018 - 00:00

MELBOURNE, Australia and SYDNEY, Australia, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

09/10/2018 - 22:48

RADNOR, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]

Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study

09/10/2018 - 22:31

Data published in the American Journal of Hematology show more than twice as many patients taking crizanlizumab did not experience a disease-related pain crisis (also called vaso-occlusive crisis, or VOC) vs placebo [...]

Acura Pharmaceuticals, Inc. Restructures Debt Obligations

09/10/2018 - 22:15

PALATINE, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) , a specialty pharmaceutical company focused on innovating abuse deterrent drugs , today announced that on October 5, 2018 we [...]

Dragon Jade to Restructure Montrose Group Acquisition

09/10/2018 - 22:15

HONG KONG, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced that it will restructure its [...]

ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting

09/10/2018 - 22:15

Abstract featuring-IMPLANT2 data awarded Prize Paper by Society for Assisted Reproductive Technology (SART) Nolasiban treatment shown to significantly increase Live Birth Rate (LBR) in randomized clinical trial of [...]

DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom

09/10/2018 - 22:05

SALUGGIA, Italy and CINCINNATI, Oct. 09, 2018 (GLOBE NEWSWIRE) -- DiaSorin S.p.A. (FTSE Italy Mid Cap: DIA) and Meridian Bioscience, Inc . (NASDAQ:VIVO) today announced that DiaSorin Inc., a subsidiary of DiaSorin S.p.A [...]

Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

09/10/2018 - 22:03

REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH) today announced the closing of its initial public offering of 14,375,000 shares of common stock, which includes the exercise in [...]

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09/10/2018 - 22:01

MENLO PARK, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at ASN Kidney Week 2018

09/10/2018 - 22:00

REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, will present new data on Veltassa® (patiromer) at the American Society of Nephrology (ASN) Kidney Week, the world’s [...]

Athersys to Host Third Quarter Financial Results Call

09/10/2018 - 22:00

CLEVELAND, Ohio, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) will release its third quarter 2018 financial results at approximately 4:00 p.m. Eastern Time on Tuesday, November 6th, 2018, and will [...]

How to Use Bleach Baths to Help Manage Eczema Flares; American Academy of Dermatology

09/10/2018 - 20:00

ROSEMONT, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Although hot water and bubble baths may sound relaxing to many, for those with atopic dermatitis, this can have the opposite effect, causing dry, scaly, red patches to [...]

Avadim Health, Inc. Announces Growth Capital Investment of $60 Million

09/10/2018 - 19:57

ASHEVILLE, N.C., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Avadim Health, Inc. (“Avadim Health”), the Bionome Therapies TM life sciences company, is pleased to announce today that it has closed a debt financing round with gross [...]

Project HOPE Honors Merck for Impact in Global Health at 60th Anniversary Gala

09/10/2018 - 19:02

Former First Lady Laura Bush Delivers Keynote Address Millwood, VA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Project HOPE honors its longest serving corporate partner, Merck and Co., Inc., for its outstanding contributions in [...]

CTD Holdings to Present at BioFlorida Conference with update on Clinical Program Using Cyclodextrins to treat diseases with Unmet Medical Needs

09/10/2018 - 18:03

ALACHUA, Fla., Oct. 09, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biopharmaceutical company that develops cyclodextrin-based products for the treatment of disease with unmet needs, [...]

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company

09/10/2018 - 17:01

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

09/10/2018 - 17:01

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

CEO Fred Angelopoulos of Maverick Technology Solutions, maker of Industry Leading ROSINBOMB Line of Products, featured at CWCB Expo LA

09/10/2018 - 16:00

Fred Angelopoulos was a featured speaker at the recent CWCB Expo in Los Angeles RENO, Nev., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC: MVRK ), innovator and manufacturer of the ROSINBOMB line [...]